David A Morrow MD MPH

Cardiac Critical Care

Professor of Medicine, Brigham and Women's Hospital

75 Francis StCardiovascular DivisionBoston, MA 02115
Phone+1 857-307-4000

Dr. Morrow is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Morrow's full profile Already have an account?

Summary

Dr. David Morrow is a cardiologist in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from Harvard Medical School and has been in practice 23 years. He specializes in adult heart disease and cardiac critical care and is experienced in critical care medicine.

Education & Training

Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1997 - 2000
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1994 - 1997
Harvard Medical SchoolClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2022 - 2028
NH State Medical License 2022 - 2028
RI State Medical License 2022 - 2028
MA State Medical License 1996 - 2027
ME State Medical License 2022 - 2027
CT State Medical License 2022 - 2026
VT State Medical License 2023 - 2026
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017

Clinical Trials

Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
COMPLETED
PHASE3

Publications & Presentations

PubMed

Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock.
Erin A Bohula, David A Morrow
Circulation. 2026-08-25
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study.
Andre M Small, Siddharth M Patel, Robert P Giugliano, David A Morrow, Erica L Goodrich
Blood. 2026-08-06
Die kunst des Fortschritts liegt darin, Ordnung inmitten des Wandels zu bewahren: 'the art of progress lies in preserving order amid change'.
Pascal Vranckx, David Morrow, Sean van Diepen, Frederik H Verbrugge
European Heart Journal. Acute Cardiovascular Care. 2026-08-03

Journal Articles

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Eugene Braunwald, David A Morrow, The New England Journal of Medicine

Lectures

Effect of Sacubitril/Valsartan on Biomarkers of Myocardial Stress in Patients Hospitalized With Acute Heart Failure in PIONEER-HF
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
High Sensitivity Troponin - Ready for Prime Time?
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Ranolazine Reduces Recurrent Ischemia in Patients with Non-ST Elevation ACS
56th Annual Scientific Session & Expo, New Orleans, Louisiana, USA

Other

C-reactive protein in cardiovascular disease
Morrow DA
http://www.uptodate.com/contents/c-reactive-protein-in-cardiovascular-disease
UpToDate, Wolters Kluwer Health - 2013-01-16
Screening for cardiovascular risk with C-reactive protein
Morrow DA
http://www.uptodate.com/contents/screening-for-cardiovascular-risk-with-c-reactive-protein
UpToDate, Wolters Kluwer Health - 2013-01-16
Troponins and creatine kinase as biomarkers of cardiac injury
Morrow DA, Jaffe AS
http://www.uptodate.com/contents/troponins-and-creatine-kinase-as-biomarkers-of-cardiac-injury
UpToDate, Wolters Kluwer Health - 2012-09-18

Press Mentions

First Hours Crucial in New Guidance for Cardiogenic ShockMarch 27th, 2025
Management of Ischaemic Stroke, Prognostic Impact of Procedural Myocardial Injury, and Antiplatelet Treatment: The Many Facets of Interventional CardiologyJanuary 30th, 2021
The Cardiac Care Unit SurvivalJune 27th, 2020